MARC details
000 -LEADER |
fixed length control field |
01996cam a2200325 a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
EG-GiCUC |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
150419s2014 ua d f m 000 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
EG-GiCUC |
Language of cataloging |
eng |
Transcribing agency |
EG-GiCUC |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
Deposite |
097 ## - Thesis Degree |
Thesis Level |
M.Sc |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Classification number |
Cai01.19.04.M.Sc.2014.Ay.T |
100 0# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Ayman Elsayed Elfakharany |
245 10 - TITLE STATEMENT |
Title |
Treatment outcomes of diffuse large B-cell non-Hodgkin{u2019}s lymphoma presenting to Tanta cancer center / |
Statement of responsibility, etc. |
Ayman Elsayed Elfakharany ; Supervised Ahmed Abdelmabood Zeeneldin , Ayman Abdelsamie Gaber , Amgad Ahmad Shaheen |
246 15 - VARYING FORM OF TITLE |
Title proper/short title |
نتائج علاج أورام الغدد الليمفاوية اللاهودجكنية المتسعة كبيرة الخلية من النوع باء في مركز أورام طنطا |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Cairo : |
Name of publisher, distributor, etc. |
Ayman Elsayed Elfakharany , |
Date of publication, distribution, etc. |
2014 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
155 P. : |
Other physical details |
charts ; |
Dimensions |
25cm |
502 ## - DISSERTATION NOTE |
Dissertation note |
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Medical Oncology |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Introduction: DLBC-NHL is the most common lymphoid neoplasm and constitutes almost 50% of all NHLs. Methods: This thesis includes 485 patients was conducted to study the outcomes in patients with DLBC-NHL among patients treated at Tanta Cancer Center (TCC) between 2003 and 2006 and followed up till March 2014. Results: 88% of patients received CTx being CHOP in 72.4% of cases. CR was achieved in 62.1%, PFS was 21.4 months. The median OS was 20 months. Conclusions: Outcomes of DBLC-NHL at TCC is comparable to those in the literature. Adding Rituximab is recommended to further improve the treatment |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
Additional physical form available note |
Issued also as CD |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
DLBC |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Egyptian National Cancer Institute |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Tanta Cancer Center |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Ahmed Abdelmabood Zeeneldin , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Amgad Ahmad Shaheen , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Ayman Abdelsamie Gaber , |
Relator term |
|
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Aml |
Reviser |
Cataloger |
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Nazla |
Reviser |
Revisor |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Thesis |